ATE188385T1 - Antithrombin iii - präparation - Google Patents

Antithrombin iii - präparation

Info

Publication number: ATE188385T1
Authority: AT; Austria
Prior art keywords: antithrombin iii; preparation; powder; solvent; alkyl ester
Prior art date: 1992-10-02

Application number

AT93115422T

Other languages

English (en)

Inventor

Toshinobu Aoyama

Keizou Hirahara

Original Assignee

Hoechst Japan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-02

Filing date

1993-09-24

Publication date

2000-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17402131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE188385(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-09-24 Application filed by Hoechst Japan filed Critical Hoechst Japan

2000-01-15 Application granted granted Critical

2000-01-15 Publication of ATE188385T1 publication Critical patent/ATE188385T1/de

Links

102000004411 Antithrombin III Human genes 0.000 title abstract 4
108090000935 Antithrombin III Proteins 0.000 title abstract 4
229960005348 antithrombin iii Drugs 0.000 title abstract 4
229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 2
239000008176 lyophilized powder Substances 0.000 abstract 2
-1 polyoxyethylene Polymers 0.000 abstract 2
239000000843 powder Substances 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Radar Systems Or Details Thereof (AREA)

AT93115422T 1992-10-02 1993-09-24 Antithrombin iii - präparation ATE188385T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP26436492A JP3494667B2 (ja)	1992-10-02	1992-10-02	アンチトロンビンｉｉｉ製剤

Publications (1)

Publication Number	Publication Date
ATE188385T1 true ATE188385T1 (de)	2000-01-15

Family

ID=17402131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93115422T ATE188385T1 (de)	1992-10-02	1993-09-24	Antithrombin iii - präparation

Country Status (12)

Country	Link
US (1)	US5385890A (de)
EP (1)	EP0590531B1 (de)
JP (1)	JP3494667B2 (de)
KR (1)	KR100264707B1 (de)
AT (1)	ATE188385T1 (de)
AU (1)	AU672430B2 (de)
CA (1)	CA2107516C (de)
DE (1)	DE69327498T2 (de)
DK (1)	DK0590531T3 (de)
ES (1)	ES2141123T3 (de)
GR (1)	GR3032580T3 (de)
PT (1)	PT590531E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3711561B2 (ja) *	1993-04-05	2005-11-02	三菱ウェルファーマ株式会社	アンチトロンビン−▲ｉｉｉ▼液状製剤およびその安定化方法
AT405905B (de) *	1997-03-25	1999-12-27	Immuno Ag	Neue verwendung von antithrombin iii
US6518406B1 (en) *	1999-06-23	2003-02-11	Octapharma Ag	Method for purification of proteins
CN114813287A (zh) *	2022-06-29	2022-07-29	深圳市帝迈生物技术有限公司	一种用于肝素抗凝检测的校准品及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS597693B2 (ja) *	1978-01-07	1984-02-20	株式会社ミドリ十字	抗トロンビン製剤及びその製法
US4613501A (en) *	1984-12-21	1986-09-23	New York Blood Center, Inc.	Inactivation of viruses in labile blood derivatives
US4841023A (en) *	1986-06-25	1989-06-20	New York Blood Center, Inc.	Inactivation of viruses in labile protein-containing compositions using fatty acids
US5319072A (en) *	1992-01-10	1994-06-07	Alpha Therapeutic Corporation	Human antithrombin-III preparation

1992
- 1992-10-02 JP JP26436492A patent/JP3494667B2/ja not_active Expired - Fee Related
1993
- 1993-09-24 DK DK93115422T patent/DK0590531T3/da active
- 1993-09-24 PT PT93115422T patent/PT590531E/pt unknown
- 1993-09-24 EP EP93115422A patent/EP0590531B1/de not_active Revoked
- 1993-09-24 AT AT93115422T patent/ATE188385T1/de not_active IP Right Cessation
- 1993-09-24 DE DE69327498T patent/DE69327498T2/de not_active Revoked
- 1993-09-24 ES ES93115422T patent/ES2141123T3/es not_active Expired - Lifetime
- 1993-09-30 US US08/128,573 patent/US5385890A/en not_active Expired - Lifetime
- 1993-10-01 AU AU48728/93A patent/AU672430B2/en not_active Ceased
- 1993-10-01 CA CA002107516A patent/CA2107516C/en not_active Expired - Fee Related
- 1993-10-02 KR KR1019930020297A patent/KR100264707B1/ko not_active Expired - Fee Related
2000
- 2000-02-04 GR GR20000400274T patent/GR3032580T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69327498T2 (de)	2000-06-08
ES2141123T3 (es)	2000-03-16
JP3494667B2 (ja)	2004-02-09
US5385890A (en)	1995-01-31
CA2107516C (en)	2004-12-07
JPH06116167A (ja)	1994-04-26
AU672430B2 (en)	1996-10-03
PT590531E (pt)	2000-05-31
EP0590531B1 (de)	2000-01-05
CA2107516A1 (en)	1994-04-03
DK0590531T3 (da)	2000-06-13
GR3032580T3 (en)	2000-05-31
KR100264707B1 (ko)	2000-09-01
DE69327498D1 (de)	2000-02-10
EP0590531A1 (de)	1994-04-06
AU4872893A (en)	1994-04-14
KR940008695A (ko)	1994-05-16

Legal Events

Date	Code	Title	Description
2003-08-15	RZN	Patent revoked

Publication	Publication Date	Title
LV10907A (lv)	1995-12-20	Interferona polietilenglikola atvasinajums
DE69132006D1 (de)	2000-04-06	Thiazolederivate als inhibitoren von aktivem sauerstoff
DK599785D0 (da)	1985-12-20	Blokpolyestere og detergentkompositioner indeholdende disse
GR1001225B (el)	1993-06-30	Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
DE3380409D1 (de)	1989-09-21	Diazabicyclo(3.3.1)nonanes
BG37995A3 (en)	1985-09-16	Method for preparing derivatives of 2- cyanbenzimidazol
BG33296A3 (bg)	1983-01-14	Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
JPS53119844A (en)	1978-10-19	Optically active amino acid-mandelic acid complexes and theire preparation
BG35328A3 (en)	1984-03-15	Method for preparing imidodisulphamidic derivatives
EP0341707A3 (en)	1990-03-14	Phenylethanol ester of ortho-cinnamic acid, its preparation and use as fragrance compound
ES2041249T3 (es)	1993-11-16	Preparaciones liquidas de 1,2-benzoisotiazolin-3-ona, su obtencion y empleo.
DE69314942D1 (de)	1997-12-04	N-acylglutamin-derivate
BG36348A3 (en)	1984-10-15	Method for preparing thienopyridinon derivatives
GR3021511T3 (en)	1997-01-31	Stable freeze dried polyhematoporphyrin ether/ester composition
DE69327498D1 (de)	2000-02-10	Antithrombin III - Präparation
DE69000719D1 (de)	1993-02-18	Hautreinigungsmittel.
BG38338A3 (en)	1985-11-15	Method for preparing 6 alpha- methylhydrocortisonic derivatives
ES2090835T3 (es)	1996-10-16	Calibrador y su uso en un ensayo inmunologico.
BG34454A3 (bg)	1983-09-15	Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
DE2960291D1 (en)	1981-08-06	Coumarin derivatives and their use as brightening agents for high molecular organic substances
JPS56118442A (en)	1981-09-17	Halogen-containing resin composition
ATE73812T1 (de)	1992-04-15	Thionophosphonsaeureester.
DE3683794D1 (de)	1992-03-19	Positiv-fotoresist-zusammensetzungen.
JPS5572116A (en)	1980-05-30	Anti-tumor agent
JPS53130632A (en)	1978-11-14	Novel oxybenozoic acid ester and bacteriostatic agent containing the same as effective component